Dong‐Woo Kim

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux

Andrea J. Luthi, Heng Zhang, Dong‐Woo Kim et al. · ACS Nano · 2011 · 71 citations · Full text

Nanoparticles, Nanomedicine, Lipid Preparation +14

Neuroprotective effects of roasted licorice, not raw form, on neuronal injury in gerbil hippocampus after transient forebrain ischemia1

In Koo Hwang, Soon-Sung Lim, Kyuhyun Choi et al. · Acta Pharmacologica Sinica · 2006 · 61 citations

Roasted Licorice, Raw Form, Neurophysiology +11

Protective effect of diphlorethohydroxycarmalol isolated from Ishige okamurae against high glucose-induced-oxidative stress in human umbilical vein endothelial cells

Soo‐Jin Heo, Ji-Young Hwang, Jung-In Choi et al. · Food and Chemical Toxicology · 2010 · 59 citations

Oxysterol, Biochemistry, Medicine +10